BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/13/2021 8:37:10 AM | Browse: 478 | Download: 985
 |
Received |
|
2021-06-28 17:47 |
|
Peer-Review Started |
|
2021-06-28 17:52 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-07-15 17:57 |
|
Revised |
|
2021-07-24 14:49 |
|
Second Decision |
|
2021-08-06 03:17 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-08-06 05:57 |
|
Articles in Press |
|
2021-08-06 05:57 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-08-17 22:37 |
|
Typeset the Manuscript |
|
2021-10-11 04:17 |
|
Publish the Manuscript Online |
|
2021-10-13 08:37 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireview
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Milica M Borovcanin, Katarina Vesic, Milena Jovanovic and Natasa R Mijailovic |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Ministry of Science and Technological Development of the Republic of Serbia |
175069 |
| Faculty of Medical Sciences, University of Kragujevac |
JP 15-05 |
|
| Corresponding Author |
Milica M Borovcanin, MD, PhD, Associate Professor, Department of Psychiatry, University of Kragujevac, Serbia, Faculty of Medical Sciences, 69 Svetozara Markovica St, Kragujevac 34000, Sumadija, Serbia. milicaborovcanin@medf.kg.ac.rs |
| Key Words |
Galectin-3; Schizophrenia; Metabolic syndrome; Insulin resistance; Cognition; Antipsychotics |
| Core Tip |
Atypical antipsychotic use could be associated with undesired metabolic effects. In this context, glycosylation has become a new target of investigation of schizophrenia pathophysiology. As a glycan, galectin-3 (Gal-3) might be involved in the inflammation-insulin resistance-obesity cascade in schizophrenia, leading to cognitive changes. Eliminating Gal-3 influence may be beneficial in preserving cognition and reestablishing metabolic balance. |
| Publish Date |
2021-10-13 08:37 |
| Citation |
Borovcanin MM, Vesic K, Jovanovic M, Mijailovic NR. Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireview. World J Diabetes 2021; 12(10): 1731-1739 |
| URL |
https://www.wjgnet.com/1948-9358/full/v12/i10/1731.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v12.i10.1731 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
